Mylan NV (MYL)

42.06
NASDAQ : Health Care
Prev Close 42.59
Day Low/High 41.95 / 42.69
52 Wk Low/High 37.59 / 55.51
Avg Volume 5.70M
Exchange NASDAQ
Shares Outstanding 534.91M
Market Cap 22.78B
EPS 1.80
P/E Ratio 26.62
Div & Yield N.A. (N.A)

Latest News

CEO Isn't All That's Under Pressure at Mylan

CEO Isn't All That's Under Pressure at Mylan

The bear is in control.

Cramer: We Got a Fake-Out From the Fed

Cramer: We Got a Fake-Out From the Fed

And what happened to all those predicting a surprise rate hike?

Stocks Up as Fed's Gradual Approach Fuels Gains, Oil Rises

Stocks Up as Fed's Gradual Approach Fuels Gains, Oil Rises

Stocks hold in the green on Thursday as relief over a patient Federal Reserve fuels market gains.

Mylan (MYL) Facing 'Huge' Financial Impact with Generic EpiPen

Mylan (MYL) Facing 'Huge' Financial Impact with Generic EpiPen

Mylan (MYL) has said that it would begin selling a generic version of the EpiPen at half the cost to help people who can't afford the drug's $600 list price.

Stocks Rise as Wall Street Cheers Fed's Patience on Interest Rates

Stocks Rise as Wall Street Cheers Fed's Patience on Interest Rates

Stocks rise Thursday as relief over a patient Federal Reserve fuels market gains.

More Squawk From Jim Cramer: Mylan (MYL) Should Have Immediately Cut EpiPen Price

More Squawk From Jim Cramer: Mylan (MYL) Should Have Immediately Cut EpiPen Price

Mylan (MYL) CEO Heather Bresch appeared before the House Oversight committee on Wednesday afternoon.

Mylan (MYL) CEO Bresch Not the Only One Benefiting from EpiPen Price Hike

Mylan (MYL) CEO Bresch Not the Only One Benefiting from EpiPen Price Hike

Mylan (MYL) CEO Heather Bresch testified about the pharma company's price hike on EpiPens before the House Oversight and Government Reform Committee on Wednesday afternoon.

Stock Futures Rise as Wall Street Finds Relief in a Patient Fed

Stock Futures Rise as Wall Street Finds Relief in a Patient Fed

Stock futures move higher on Thursday as relief over a patient Federal Reserve fuels market gains for a second day.

5 Things You Must Know Before the Market Opens Thursday

5 Things You Must Know Before the Market Opens Thursday

U.S. stock futures edge higher after the Federal Reserve leaves interest rates unchanged; a report says Yahoo! may confirm this week a massive data breach of its service.

Mylan's First Date With Congress Proves 'Painful'

Mylan's First Date With Congress Proves 'Painful'

Mylan's MYL CEO Heather Bresch appeared in the House of Representatives to testify on the rising prices of EpiPens.

'Cheap Shot' to Bring Her Mother Into EpiPen Controversy, Mylan (MYL) CEO Says

'Cheap Shot' to Bring Her Mother Into EpiPen Controversy, Mylan (MYL) CEO Says

Mylan (MYL) CEO Heather Bresch testified about the pharma company's price hike on EpiPens before the House Oversight and Government Reform Committee today in a hearing on Capitol Hill.

Mylan (MYL) CEO Bresch Grilled by Rep. Cummings at Hearing

Mylan (MYL) CEO Bresch Grilled by Rep. Cummings at Hearing

Mylan (MYL) CEO Heather Bresch testified about the pharma company's price hike on EpiPens before the House Oversight and Government Reform Committee today in a hearing on Capitol Hill.

EpiPen Controversy: Mylan's Tough Week Just Keeps Getting Grimmer

EpiPen Controversy: Mylan's Tough Week Just Keeps Getting Grimmer

Brace for extreme turbulence as Mylan's chief executive testifies before Congress and faces further public condemnation.

Mylan (MYL) CEO Faces Hearing After Wells Fargo CEO Blasted by Senate

Mylan (MYL) CEO Faces Hearing After Wells Fargo CEO Blasted by Senate

Mylan (MYL) CEO Heather Bresch will testify before Congress on Wednesday, a day after Wells Fargo (WFC) CEO John Stumpf was grilled by a Senate committee.

Morning Movers: MYL, XOM, MSFT, GIS, CLVS

Wall Street eyes the Fed's decision on interest rates as Mylan's CEO goes to Capital Hill over the EpiPen.

What to Expect When Mylan CEO Appears Before House Committee

What to Expect When Mylan CEO Appears Before House Committee

The executive will testify before the House Committee on Oversight and Government Reform Wednesday.

5 Things You Must Know Before the Market Opens Wednesday

5 Things You Must Know Before the Market Opens Wednesday

U.S. stock futures rise ahead of the Federal Reserve's decision on interest rates and after the Bank of Japan tweaks monetary policy.

Bank of Japan Takes Surprise Step to Spark Inflation in Policy Revamp

Bank of Japan Takes Surprise Step to Spark Inflation in Policy Revamp

The Bank of Japan introduces a zero percent interest-rate target for 10 year government bonds to step up its fight against deflation.

Mylan (MYL) Stock Up Despite West Virginia EpiPen Fraud Investigation

Mylan (MYL) Stock Up Despite West Virginia EpiPen Fraud Investigation

West Virginia's attorney general is investigating Mylan (MYL) over its EpiPen product, specifically if the company overcharged the state's Medicaid program.

Valeant's $1.5 Billion 'Capital Hole' -- and $31 Billion in Debt

Valeant's $1.5 Billion 'Capital Hole' -- and $31 Billion in Debt

It may not be possible for Valeant to wind down its massive debt as quickly as expected, say Deutsche Bank analysts.

Stressed Out: Valeant May Need $1.5B New Debt to Fill 'Capital Hole'

Stressed Out: Valeant May Need $1.5B New Debt to Fill 'Capital Hole'

It may not be possible for Valeant to wind down its massive debt as quickly as expected, say Deutsche Bank analysts.

Perrigo Could Rake In $2.8 Billion in Tysabri Divestitures, Analysts Say

Perrigo Could Rake In $2.8 Billion in Tysabri Divestitures, Analysts Say

The company could divest non-core assets after Starboard Value revealed a 4.6% stake.

Arbor and Purdue Seen as Likely Bidders for DepoMed

Arbor and Purdue Seen as Likely Bidders for DepoMed

The pharmaceutical company is reportedly up for sale after being dogged by Starboard Value for months, and could go for up to $41 million.

Mylan (MYL), Wells Fargo CEOs to Testify This Week

Mylan (MYL), Wells Fargo CEOs to Testify This Week

Mylan (MYL) CEO Heather Bresch and Wells Fargo (WFC) CEO John Stumpf will testify before Congress this week.

EpiPen Maker Mylan Gives 'Generous' Executive Pay

EpiPen Maker Mylan Gives 'Generous' Executive Pay

Mylan dealing with more negative reports, this time for executive pay.

Morning Movers: BAYRY, MON, WFC, JPM, MYL

Morning Movers: BAYRY, MON, WFC, JPM, MYL

Bayer has agreed to purchase Monsanto for $66 billion, or $128 a share, a 20% premium over its previous closing price.

House Republicans Question EpiPen's Generic Status

House Republicans Question EpiPen's Generic Status

The U.S. Centers for Medicare and Medicaid allowed Mylan's EpiPen to receive a generic classification for years, allowing the company to pay lower rebates.

5 Healthy Pharma and Biotech Plays

5 Healthy Pharma and Biotech Plays

These stocks look good as seasonal volatility sets in.